Shenkman Capital Management »

Cytokinetics shares owned by Shenkman Capital Management

Quarter-by-quarter ownership of Cytokinetics shares owned by Shenkman Capital Management from 13F filings

Historical chart of Shenkman Capital Management investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Shenkman Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Shenkman Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $521M 400k 1303.25
2024-06-30 $662M 500k 1324.46
2023-12-31 $3.0B 1.7M 1777.50

More positions owned by Shenkman Capital Management

Ishares Tr Broad Usd High (USHY)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Southwest Airls Note 1.250% 5/0 (Principal)
Digitalocean Hldgs Note 12/0 (Principal)
Dexcom Note 0.375% 5/1 (Principal)
Uber Technologies Note 12/1 (Principal)
Rapid7 Note 1.250% 3/1 (Principal)
Teladoc Health Note 1.250% 6/0 (Principal)
Ionis Pharmaceuticals Note 4/0 (Principal)
Wolfspeed Note 1.750% 5/0 (Principal)
Guardant Health Note 11/1 (Principal)
Itron Note 3/1 (Principal)
Shift4 Pmts Note 0.500% 8/0 (Principal)
Tree (TREE)
On Semiconductor Corp Note 0.500% 3/0 (Principal)

View all positions for Shenkman Capital Management

Top funds holding Cytokinetics

Wolverine Asset Management
Balyasny Asset Management
Lazard Asset Management
Point72 Asset Management
D. E. Shaw & Co
Readystate Asset Management
Aequim Alternative Investments
Polygon Management
State Street Corporation
DeepCurrents Investment Group
Bank of America Corporation
Morgan Stanley
Schroder Investment Management Group
BlackRock
BlackRock

View all funds holding Cytokinetics